9-37887879-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033412.4(SLC25A51):c.672G>T(p.Met224Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000206 in 1,611,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
SLC25A51
NM_033412.4 missense
NM_033412.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.80
Genes affected
SLC25A51 (HGNC:23323): (solute carrier family 25 member 51) Enables NAD transmembrane transporter activity. Involved in mitochondrial NAD transmembrane transport. Located in mitochondrion. Is active in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12754762).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC25A51 | NM_033412.4 | c.672G>T | p.Met224Ile | missense_variant | 3/3 | ENST00000242275.7 | |
SLC25A51 | NR_024872.3 | n.210-6248G>T | intron_variant, non_coding_transcript_variant | ||||
SLC25A51 | NR_024873.3 | n.183-6248G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC25A51 | ENST00000242275.7 | c.672G>T | p.Met224Ile | missense_variant | 3/3 | 2 | NM_033412.4 | P1 | |
SLC25A51 | ENST00000496760.5 | n.409-6248G>T | intron_variant, non_coding_transcript_variant | 1 | |||||
SLC25A51 | ENST00000377716.6 | c.672G>T | p.Met224Ile | missense_variant | 3/3 | 3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
27
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000271 AC: 68AN: 250990Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135702
GnomAD3 exomes
AF:
AC:
68
AN:
250990
Hom.:
AF XY:
AC XY:
39
AN XY:
135702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000209 AC: 305AN: 1459768Hom.: 0 Cov.: 34 AF XY: 0.000187 AC XY: 136AN XY: 726192
GnomAD4 exome
AF:
AC:
305
AN:
1459768
Hom.:
Cov.:
34
AF XY:
AC XY:
136
AN XY:
726192
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74356
GnomAD4 genome
AF:
AC:
27
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
9
ExAC
AF:
AC:
47
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.672G>T (p.M224I) alteration is located in exon 3 (coding exon 1) of the SLC25A51 gene. This alteration results from a G to T substitution at nucleotide position 672, causing the methionine (M) at amino acid position 224 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of catalytic residue at M224 (P = 0.0029);Gain of catalytic residue at M224 (P = 0.0029);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at